Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005012 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
A Phase 2 study, sponsored by Schering-Plough.
- Completed
- Registry status
- Phase 2
- Development phase
- 250
- Enrollment target
NCT00005012: Completed Phase 2 study, sponsored by Schering-Plough.
NCT00005012 is a Phase 2 study that has completed, run by Schering-Plough. The registered enrollment target is 250 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (88% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005012, a Phase 2 study, has completed, sponsored by Schering-Plough.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to see if it is effective to give PEG-Intron (PEG-IFN) to HIV-infected patients who are not doing well with their current anti-HIV drug combination (HAART).
Interventions
- DRUG Peginterferon alfa-2b
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2000-03 |
| Est. Completion | 2000-09 |
| Phase | Phase 2 |
What the finished NCT00005012 record still lists
NCT00005012 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (88% higher).
The record links to 0 conditions, and to 1 intervention - of which Peginterferon alfa-2b is the first listed.
NCT00005012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005012 about?
NCT00005012 is a clinical study titled "Safety and Effectiveness of PEG-Intron in HIV-Infected Patients". The purpose of this study is to see if it is effective to give PEG-Intron (PEG-IFN) to HIV-infected patients who are not doing well with their current anti-HIV drug combination (HAART).
What is the current status of trial NCT00005012?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 250 participants. The study started on 2000-03. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00005012?
The interventions under investigation include: Peginterferon alfa-2b (DRUG).
Who is sponsoring clinical trial NCT00005012?
This trial is sponsored by Schering-Plough, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00005012's enrollment target sits among peer trials
250 222nd of 2000 higher than 1,768 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia